ClinicalTrials.Veeva

Menu

Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Heart Failure

Study type

Observational

Funder types

Other

Identifiers

NCT02303236
H-1-2012-092-B

Details and patient eligibility

About

Establishing the association between biological markers and exercise capacity in continuous-flow left ventricular assist device patients.

Full description

The aim of this study is to investigate if specific biological markers can predict exercise capacity in advanced heart failure patients supported with continuous-flow left ventricular assist device patients.

Enrollment

25 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stable CF-LVAD patients.

Exclusion criteria

  • Unstable CF-LVAD patients.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems